ibrutinib,venetoclax
abbvie,janssen,roche
['dlbcl', ' ibru', 'lymsm']
laudable &amp; honest discussion of adverse events &amp; timeline by dr castillo -
hopefully will be overcome by future use of other btkis instead of ibrutinib (second clause mine not dr c's) #ash22 #lymsm #wm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer